Breaking News, Financial News

1Q Financial Report: Fisher Scientific

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fisher Scientific 1Q Revenues: $1.4 billion (+8%) 1Q Earnings: $103.2 million (+34%) Comments: Income from continuing operations increased to $106.2 million, up 39% for the quarter. Cash from operations totaled $111.2 million, reflecting growth in earnings. Healthcare product sales and services increased to $353.5 million, up 8%. Sales of scientific products and services totaled $1.1 billion, up 9%....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters